Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial

PLoS Medicine(2022)10.1371/journal.pmed.1004104Source: DataRank Database

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial is a research paper published in PLoS Medicine (2022). On theSindex it has a DataRank of 0.529. It has been cited 7 times, with 6 citing works in its 1-hop citation network.

N/A

0.529DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access7 citations · 6 citing works in its network

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT03178643
PACTRPACTR201707002371165

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.16)OA: goldTopics (87)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 59%Citation Network 41%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

0.217

From 5 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 6 citers.

Effectiveness of sulfadoxine–pyrimethamine plus amodiaquine and dihydroartemisinin–piperaquine for seasonal malaria chemoprevention in Uganda: a three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trial
The Lancet Infectious Diseases202513 citations23 referencesContributes 0.115
Weekly dihydroartemisinin–piperaquine versus monthly sulfadoxine–pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial
The Lancet Infectious Diseases20246 citations25 referencesContributes 0.078
FIGO good practice recommendations on anemia in pregnancy, to reduce the incidence and impact of postpartum hemorrhage ( PPH )
International Journal of Gynecology & Obstetrics202516 citations111 referencesContributes 0.026
Treating sickle cell disease in resource-limited sub-Saharan Africa: recent strategies and recommendations in addressing the gaps for the provision of evidence-based management
Expert Review of Hematology202511 citations135 referencesContributes 0.018
“I want to help my body”: Acceptability of malaria chemoprevention among children with sickle cell anaemia and their caregivers in Malawi and Uganda
PLOS Global Public Health20252 citations60 referencesContributes 0.018

Authors (9)

Sarah Korwa,Angie Wu,Cynthia L. Green ORCID,Betsy Freedman,Sheila Clapp

Live enrichment

PubMed:36215323 PMC:PMC9591057 OpenAlex:https://openalex.org/W4304086171

National Heart, Lung, and Blood Institute

Grant: R01HL134211

National Institutes of Health

Grant: 5R01HL134211-03

Malaria chemoprevention in children with sickle cell anemia in Western Kenya

Guilin Pharmaceuticals

FWCI

1.16

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pmed.1004104

publisherhttps://doi.org/10.1371/journal.pmed.1004104

publisherhttps://dx.plos.org/10.1371/journal.pmed.1004104

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36215323

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9591057

Fields of Study

Malaria Research and ControlHemoglobinopathies and Related DisordersParasites and Host Interactions03 medical and health sciences0302 clinical medicineChildChild, PreschoolFemaleHumansInfantMaleAmodiaquineAnemia, Sickle CellAntimalarialsArtemisininsChemopreventionDrug CombinationsHydroxyureaKenyaMalariaMalaria, FalciparumProguanilPyrimethamineSulfadoxinePiperazinesQuinolines

MeSH Terms

AmodiaquineAnemia, Sickle CellAntimalarialsChildChild, PreschoolProguanilDrug CombinationsFemaleHumansHydroxyureaInfantKenyaMalariaMalePiperazinesPyrimethamineQuinolinesSulfadoxineMalaria, FalciparumChemopreventionArtemisinins

Keywords

AmodiaquinePiperaquineMedicineMalariaSulfadoxineMefloquineKenyaSulfadoxine/pyrimethaminePyrimethamineAnemiaRandomized controlled trialChloroquinePediatricsPharmacologyInternal medicineArtemisininImmunologyPlasmodium falciparumBiologyMale610Anemia, Sickle CellChemopreventionPiperazinesAntimalarialsHumansHydroxyureaMalaria, FalciparumChildChildrenRInfantArtemisininsMalaria chemopreventionDrug CombinationsProguanilChild, PreschoolSickle cell anemiaFemaleResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Related Papers (1)

Changing Prevalence of Potential Mediators of Aminoquinoline, Antifolate, and Artemisinin Resistance Across Uganda

The Journal of Infectious Diseases(2020)

co-cited

10.1093/infdis/jiaa687

Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial

FAIR Checklist

DataRank Breakdown

Top 5 citers driving the network score

Authors (9)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)

Related Papers (1)